Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
Condition(s) studied
Investigational drug(s) / intervention(s)
metabolic surgery with SLEEVE technique: metabolic surgery with SLEEVE technique
metabolic surgery with BY-PASS technique: metabolic surgery with BY-PASS technique
Study summary
Surgery is one of the management options for type 2 diabetes in patients with moderate obesity. This is a recent option because it has been part of the recommendations since October 2022.
The possible surgical techniques are the same as those for bariatric surgery:
* Sleeve,
* Bypass,
* Gastric band, but the main goal is not weight loss, it is remission of type 2 diabetes. It is called metabolic surgery.
The ring technique (gastroplasty) is practiced less and less in France because it is less effective in weight loss and is responsible for major discomfort.
Currently, metabolic surgery is one of the recommendations but no study has compared the effectiveness of the techniques with each other. One or other of the techniques can be chosen according to the preferences of the surgeon, the patient, the center, etc. but this choice is not made objectively, in the absence of comparative data.
This study would like to follow up on patients for whom metabolic surgery has been proposed by the doctor,.
If the surgery is accepted, this study would like to improve knowledge of the effectiveness of the different techniques, and thus demonstrate which metabolic surgery technique is preferred in terms of effectiveness and safety.
Eligibility
Primary outcome measure(s)
- T2DM remission rate — 1 year after surgery
HbA1c lower than 6.5% in the absence of antidiabetic treatment, partial, complete, prolonged remission or no remission between the 2 surgical techniques
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Medipole Lyon Villeurbanne | Villeurbanne | France | Recruiting |
More Médipôle Lyon-Villeurbanne trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06600555 on ClinicalTrials.gov ↗ ← All trials in France